- $801.08m
- $669.44m
- $0.21m
Brief: Chimerix To Report Third Quarter 2022 Financial Results And Provide An Operational Update On November 3, 2022
Cowen expects smallpox drug to offset Emergent Bio's uncertainty over vaccine
U.S. STOCKS ON THE MOVE-Astra Space, Ammo, Chimerix
Chimerix surges on supply deal with U.S. govt for smallpox drug
Brief: Chimerix Awarded Barda Contract For Tembexa As Medical Countermeasure For Smallpox
Brief: Chimerix Reports Second Quarter 2022 Financial Results And Provides Operational Update
Chimerix Inc reports results for the quarter ended in June - Earnings Summary
Smallpox drugmakers rise as U.S. declares monkeypox 'public health emergency'
U.S. STOCKS ON THE MOVE-ToughBuilt Industries Inc, Koss Corp, Centene Corp
U.S. STOCKS ON THE MOVE-Lakeland Financial, World Wrestling Entertainment, Bank of Marin
Refinitiv Newscasts - US Morning Call: Fed, earnings keep markets on their toes
U.S. STOCKS ON THE MOVE-Soligenix, Veru, American Express
U.S. STOCKS ON THE MOVE-Tesla Inc, MP Materials Corp, Revelation Bioscience
Smallpox drugmakers surge after monkeypox declared health emergency
Brief: Chimerix Inc Continues To Engage In Negotiations With Barda
U.S. STOCKS ON THE MOVE-Virgin Orbit, ETSY, Coinbase, Peloton
U.S. STOCKS ON THE MOVE-Robinhood, Spirit Airlines, Polestar, Axsome Therapeutics
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Polestar, Chinese ADRs
Smallpox drugmakers fall as WHO says monkeypox not yet global health emergency